Corcept Therapeutics, Inc. (CORT)
81.52
+0.40
(+0.49%)
USD |
NASDAQ |
Dec 17, 11:54
Corcept Therapeutics Accounts Payable (Quarterly): 34.45M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amgen, Inc. | 2.838B |
| Gilead Sciences, Inc. | 808.00M |
| United Therapeutics Corp. | 468.00M |
| Vertex Pharmaceuticals, Inc. | 420.30M |
| Theravance Biopharma, Inc. | 2.213M |